Skip to main content
Log in

Minimally invasive radioguided parathyroidectomy for hyperparathyroidism

  • Invited Review Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Clinical or subclinical hyperparathyroidism (HPT) is one of the most common endocrine disorders. In patients with HPT who meet the indications for parathyroidectomy, complete surgical resection of all hyperfunctioning parathyroid tissue is essential for the curative treatment. The conventional surgical approach is bilateral neck exploration, whereas minimally invasive parathyroidectomy has been made possible by the introduction of 99mTc-sestamibi scintigraphy for preoperative localization of parathyroid adenomas. In minimally invasive surgery, the surgeon expects some modalities that predict complete resection of all hyperfunctioning parathyroid glands. The prevalence rate of 99mTc-sestamibi scanning for single parathyroid adenoma was widely accepted as 85–95%. Moreover, the recent developing technology of semiconductor electronics has produced useful portable γ-probes. Intraoperative navigation using these devices provides the possibility of easy and definitive identification of parathyroid nodules during the operation. In minimally invasive radioguided parathyroidectomy using γ-probe, different protocols are based on different timing and doses of tracer injected. Each procedure is technically easy, safe, with a low morbidity rate, and has better cosmetic results and lower overall cost than conventional bilateral neck exploration. We have applied this technique in selected patients and achieved success comparable to that achieved with contemporaneously performed standard neck exploration. In the hands of a competent surgeon, the use of sestamibi scanning and radioguided parathyroidectomy in appropriately selected patients is a useful technique.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15

Similar content being viewed by others

References

  1. Palmér M, Jakobsson S, Akerström G, Ljunghall S. Prevalence of hypercalcemia in a health survey: a 14-year follow-up study of serum calcium values. Eur J Clin Invest. 1998;18:39–46.

    Article  Google Scholar 

  2. Appleton JL. The hypertrophy of the submaxillary gland in the albino rat, following parathyroidectomy. Am J Pathol. 1925;1:217–23.

    PubMed  Google Scholar 

  3. Kaplan EL, Yashiro T, Salti G. Primary hyperparathyroidism in the 1990s: choice of surgical procedures for this disease. Ann Surg. 1992;215:301–7.

    Article  Google Scholar 

  4. Auguste LJ, Attie JN, Schnaap D. Initial failure of surgical exploration in patients with primary hyperparathyroidism. Am J Surg. 1990;160:333–6.

    Article  CAS  PubMed  Google Scholar 

  5. van Heerden JA, Grant CS. Surgical treatment of primary hyperparathyroidism: an institutional perspective. World J Surg. 1991;15:688–92.

    Article  PubMed  Google Scholar 

  6. Chen H, Zeiger MA, Gordon TA, Udelsman R. Parathyroidectomy in Maryland: effects of an endocrine center. Surgery. 1996;120:948–52.

    Article  CAS  PubMed  Google Scholar 

  7. Chen H, Mack E, Starling JR. Radioguided parathyroidectomy is equally effective for both adenomatous and hyperplastic glands. Ann Surg. 2003;238:332–7.

    Article  PubMed  Google Scholar 

  8. Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg. 2002;235:665–70.

    Article  PubMed  Google Scholar 

  9. Mariani G, Gulec SA, Rubello D, Boni G, Puccini M, Pelizzo MR, et al. Preoperative localization and radioguided parathyroid surgery. J Nucl Med. 2003;44:1443–58.

    PubMed  Google Scholar 

  10. Russell CF, Edis AJ. Surgery for primary hyperparathyroidism: experience with 500 consecutive cases and evaluation of the role of surgery in the asymptomatic patient. Br J Surg. 1982;69:244–7.

    Article  CAS  PubMed  Google Scholar 

  11. Ammori BJ, Madan M, Gopichandran TD, Price JJ, Whittaker M, Ausobsky JR, et al. Ultrasound guided unilateral neck exploration for sporadic primary hyperparathyroidism: is it worthwhile? Ann R Coll Surg Engl. 1998;80:433–7.

    CAS  PubMed  Google Scholar 

  12. Geatti O, Shapiro B, Orsolon PG, Proto G, Guerra UP, Antonucci F, et al. Localization of parathyroid enlargement: experience with technetium 99m methoxyisobutylisonitrile and thallium-201 scintigraphy, ultrasound and computed tomography. Eur J Nucl Med. 1994;21:17–23.

    Article  CAS  PubMed  Google Scholar 

  13. Casara D, Rubello D, Pelizzo MR, Shapiro B. Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism. Eur J Nucl Med. 2001;28:1351–9.

    Article  CAS  PubMed  Google Scholar 

  14. Eisenberg H, Pallotta J, Sacks B, Brickman AS. Parathyroid localization, three-dimensional modeling, and percutaneous ablation techniques. Endocrinol Metab Clin North Am. 1989;18:659–700.

    CAS  PubMed  Google Scholar 

  15. Mitchell BK, Merrel RC, Kinder BK. Localization studies in patients with hyperparathyroidism. Surg Clin North Am. 1995;75:483–98.

    CAS  PubMed  Google Scholar 

  16. Koong HN, Choong LH, Soo KC. The role of preoperative localisation techniques in surgery for hyperparathyroidism. Ann Acad Med Singapore. 1998;27:192–5.

    CAS  PubMed  Google Scholar 

  17. Levin KE, Clark OH. Localization of parathyroid glands. Annu Rev Med. 1988;39:29–40.

    Article  CAS  PubMed  Google Scholar 

  18. Lee VS, Spritzer CE, Coleman RE, Wilkinson RH Jr, Coogan AC, Leight GS Jr. The complementary roles of fast spin-echo MR imaging and double-phase 99mTc-sestamibi scintigraphy for localization of hyperfunctioning parathyroid glands. AJR. 1996;167:1555–62.

    CAS  PubMed  Google Scholar 

  19. Lee VS, Spritzer CE. MR imaging of abnormal parathyroid glands. AJR. 1998;170:1097–103.

    CAS  PubMed  Google Scholar 

  20. Billotey C, Sarfati E, Aurengo A, Duet M, Mündler O, Toubert ME, et al. Advantages of SPECT in technetium-99 m-sestamibi parathyroid scintigraphy. J Nucl Med. 1996;37:1773–8.

    CAS  PubMed  Google Scholar 

  21. Carty SE, Worsey MJ, Virji MA, Brown ML, Watson CG. Concise parathyroidectomy: the impact of preoperative SPECT 99mTc sestamibi scanning and intraoperative quick parathormone assay. Surgery. 1997;122:1107–16.

    Article  CAS  PubMed  Google Scholar 

  22. Gallowitsch HJ, Mikosch P, Kresnik E, Gomez I, Lind P. Technetium-99m-tetrofosmin parathyroid imaging: results with double-phase study and SPECT in primary and secondary hyperparathyroidism. Invest Radiol. 1997;32:459–65.

    Article  CAS  PubMed  Google Scholar 

  23. Neumann DR, Esselstyn CB Jr, Go RT, Wong CO, Rice TW, Obuchowsky NA. Comparison of double-phase 99mTc-sestamibi with 123I–99mTc-sestamibi subtraction SPECT in hyperparathyroidism. AJR. 1997;169:1671–4.

    CAS  PubMed  Google Scholar 

  24. Francis IS, Loney EL, Buscombe JR, Thakrar DS, Berger L, Hilson AJW. Technetium-99m-sestamibi dual-phase SPECT imaging: concordance with ultrasound. Nucl Med Commun. 1999;20:487–8.

    Article  Google Scholar 

  25. Akerstrom G, Malmaeus J, Bergstrom R. Surgical anatomy of human parathyroid glands. Surgery. 1984;95:14–21.

    CAS  PubMed  Google Scholar 

  26. Numano M, Tominaga Y, Uchida K, Orihara A, Tanaka Y, Takagi H. Surgical significance of supernumerary parathyroid glands in renal hyperparathyroidism. World J Surg. 1998;22:1098–102.

    Article  CAS  PubMed  Google Scholar 

  27. Bringhurst FR, Stern AM, Yotts M, Mizrahi N, Segre GV, Potts JT Jr. Peripheral metabolism of parathyroid hormone in vivo: influence of alterations in calcium availability and parathyroid status. J Endocrinol. 1989;122:237–45.

    Article  CAS  PubMed  Google Scholar 

  28. Irvin GL 3rd. American Association of Endocrine Surgeons presidential address: Chasin’ hormones. Surgery. 1999;126:993–7.

    Article  PubMed  Google Scholar 

  29. Irvin GL 3rd, Carneiro DM. Rapid parathyroid hormone assay guided exploration. Oper Tech Gen Surg. 1999;1:18–27.

    Article  Google Scholar 

  30. Irvin GL 3rd, Dembrow VD, Prudhomme DL. Operative monitoring of parathyroid gland hyperfunction. Am J Surg. 1991;162:299–302.

    Article  PubMed  Google Scholar 

  31. Nussbaum SR, Thompson AR, Hutcheson KA, Gaz RD, Wang CA. Intraoperative measurement of parathyroid hormone in the surgical management of hyperparathyroidism. Surgery. 1988;104:1121–7.

    CAS  PubMed  Google Scholar 

  32. Sokoll LJ, Drew H, Udelsman R. Intraoperative parathyroid hormone analysis: a study of 200 consecutive cases. Clin Chem. 2000;46:1662–8.

    CAS  PubMed  Google Scholar 

  33. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation. 1990;82:1826–38.

    CAS  PubMed  Google Scholar 

  34. Harioka T, Odori T, Kohno S, Tanada S, Dodo Y, Todo G, et al. CT evaluation of parathyroid tumor. Nippon Igaku Hoshasen Gakkai Zasshi. 1984;44:948–55.

    CAS  PubMed  Google Scholar 

  35. Melloul M, Paz A, Koren R, Cytron S, Feinmesser R, Gal R. 99mTc-MIBI scintigraphy of parathyroid adenomas and its relation to tumour size and oxyphil cell abundance. Eur J Nucl Med. 2001;28:209–13.

    Article  CAS  PubMed  Google Scholar 

  36. Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med. 1992;33:1801–7.

    CAS  PubMed  Google Scholar 

  37. McBiles M, Lambert AT, Cote MG, Kim SY. Sestamibi parathyroid imaging. Semin Nucl Med. 1995;25:221–34.

    Article  CAS  PubMed  Google Scholar 

  38. Martinez DA, King DR, Romshe C, Lozano RA, Morris JD, O’Dorisio MS, et al. Intraoperative identification of parathyroid gland pathology: a new approach. J Pediatr Surg. 1995;30:1306–9.

    Article  CAS  PubMed  Google Scholar 

  39. Norman J, Chheda H. Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery. 1997;122:998–1003.

    Article  CAS  PubMed  Google Scholar 

  40. Murphy C, Norman J. The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery. 1999;126:1023–8.

    Article  CAS  PubMed  Google Scholar 

  41. McGreal G, Winter DC, Sookhai S, Evoy D, Ryan M, O’Sullivan GC, et al. Minimally invasive, radioguided surgery for primary hyperparathyroidism. Ann Surg Oncol. 2001;8:856–60.

    Article  CAS  PubMed  Google Scholar 

  42. You CJ, Zapas JL. Diminished dose minimally invasive radioguided parathyroidectomy: a case for radioguidance. Am Surg. 2007;73:669–72.

    PubMed  Google Scholar 

  43. Pitt SC, Panneerselvan R, Sippel RS, Chen H. Radioguided parathyroidectomy for hyperparathyroidism in the reoperative neck. Surgery. 2009;146:592–8.

    Article  PubMed  Google Scholar 

  44. Rubello D, Casara D, Giannini S, Piotto A, De Carlo E, Muzzio PC, et al. Importance of radio-guided minimally invasive parathyroidectomy using hand-held gamma probe and low 99mTc-MIBI dose: technical considerations and long-term clinical results. Q J Nucl Med. 2003;47:224–32.

    Google Scholar 

  45. Casara D, Rubello D, Cauzzo C, Pelizzo MR. 99mTc-MIBI radio-guided minimally invasive parathyroidectomy: experience with patients with normal thyroids and nodular goiters. Thyroid. 2002;12:53–61.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshifumi Ikeda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ikeda, Y., Takayama, J. & Takami, H. Minimally invasive radioguided parathyroidectomy for hyperparathyroidism. Ann Nucl Med 24, 233–240 (2010). https://doi.org/10.1007/s12149-010-0366-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-010-0366-x

Keywords

Navigation